(Q39836531)

English

PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial

scientific article published on September 17, 2010

Statements

PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial (English)
PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial (English)
Jacqueline Aussie
Harry Rittenhouse
Roger Rittmaster

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit